Bristol-Myers Squibb unit Celgene has dropped a lawsuit accusing Indian generics company Dr Reddy’s Laboraties of threatening to infringe its patent for Revlimid with the planned launch of a generic version of the blockbuster cancer drug in Australia.
An Australian fashion designer suing Katy Perry over the rights to use the Katy Perry trade mark in Australia is a “calculating and dishonest witness” whose “utterly dishonest” testimony should not be believed, counsel for the pop star said during closing submissions.
A judge has revoked two patents held by national fitness chain F45 for a computer-run trainer workout system.
Plumbing company Repipe has asked the High Court to take up its case centred on the controversial issue of patent eligibility for computer-implemented inventions, seeking to overturn a judgment it argues sets a new and impermissible test.
Apple has fired back in a lawsuit alleging its iPhone and iPad devices equipped with Touch ID and Face ID technology infringe patents held by an Australian non-practicing entity, hitting the company with its own case claiming the patents are invalid.
Burger giant Hungry Jack’s has lost its bid to have McDonald’s hand over test results showing the âpre-cookedâ weight of its Big Mac beef patties, with a judge finding they were not relevant to whether the rivalâs Big Jack burger had 25 per cent âmore Aussie beefâ.
The Full Federal Court has shot down plumbing company Repipeâs appeal of a decision rejecting its innovation patents for a claimed computer-implemented invention, saying it only addressed issues in business operations rather than improving on computer technology.
Indian generics giant Dr Reddyâs Laboratories must give Bristol-Myers Squib unit Celgene Corporation three monthsâ notice before deciding to sell generic versions of blockbuster cancer drug Revlimid in Australia.
US pop star Katy Perry has been accused of using her âfinancial mightâ to âsnuff outâ the small business of an Australian fashion designer, as trial kicked off in a long-running intellectual property dispute over the rights to use the Katy Perry trade mark in Australia.
Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.